TMB

Biomarker

Also known as: TMB

Related News

Genomics and Spatial Multiomics Advance Precision Medicine from Research to Clinical Practice

Mar 05, 2026

Whole genome sequencing, comprehensive genomic profiling, and spatial multiomics are transforming precision medicine from research tools to clinical applications in oncology, rare diseases, and neonatal care, enabling faster diagnoses and personalized treatments.

Biomarkers and T Cell Traits Emerge as Key Predictors of Cancer Immunotherapy Response

Feb 17, 2026

New research identifies circulating tumor-reactive T cell characteristics and inflammatory biomarkers as predictive indicators for immune checkpoint inhibitor response in cancer patients, while the PD-L1 testing market is projected to reach $36.44 billion by 2032.